Walleye Trading
GBT

Walleye Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Walleye Trading’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-80,900
Closed -$5.51M – 5824
2022
Q3 		$5.51M Buy
+80,900
New +$4.46M 0.02% 964
2022
Q2 		– Sell
-1,000
Closed -$35K – 5912
2022
Q1 		$35K Sell
1,000
-600
-38% -$17.9K ﹤0.01% 4617
2021
Q4 		$47K Sell
1,600
-3,900
-71% -$121K ﹤0.01% 4696
2021
Q3 		$140K Sell
5,500
-38,600
-88% -$1.13M ﹤0.01% 4171
2021
Q2 		$1.54M Buy
44,100
+3,800
+9% +$148K 0.01% 1730
2021
Q1 		$1.64M Sell
40,300
-123,000
-75% -$5.65M 0.01% 1484
2020
Q4 		$7.07M Buy
163,300
+154,700
+1,799% +$7.63M 0.03% 548
2020
Q3 		$474K Buy
8,600
+8,100
+1,620% +$515K ﹤0.01% 2288
2020
Q2 		$32K Sell
500
-6,400
-93% -$439K ﹤0.01% 3909
2020
Q1 		$353K Buy
6,900
+2,000
+41% +$134K ﹤0.01% 2165
2019
Q4 		$390K Sell
4,900
-11,100
-69% -$658K ﹤0.01% 2618
2019
Q3 		$776K Buy
16,000
+3,400
+27% +$177K 0.01% 1789
2019
Q2 		$663K Buy
12,600
+1,900
+18% +$109K 0.01% 1954
2019
Q1 		$566K Buy
10,700
+9,500
+792% +$467K ﹤0.01% 2168
2018
Q4 		$49K Buy
+1,200
New +$45K ﹤0.01% 4148
2018
Q1 		– Sell
-4,900
Closed -$193 – 4905
2017
Q4 		$193 Buy
+4,900
New +$183K ﹤0.01% 3472

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's GBT Position: Q2 2022 in Review

Walleye Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2022, closing a stake of 4,663 shares — an estimated $162K sold.

Walleye Trading first reported a position in GBT in Q4 2017 and held it in 7 quarters. The position peaked at $3.38M in Q4 2020. 195 funds tracked by Wall St. Rank hold GBT as of Q2 2022.

  • Walleye Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
  • Walleye Trading sold 4,663 Global Blood Therapeutics, Inc. shares in Q2 2022, an estimated $162K.
  • Walleye Trading first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 7 quarters.
  • Walleye Trading's Global Blood Therapeutics, Inc. position peaked at $3.38M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.